Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    ... (IV) infusion, in subjects with relapsed and/or primary refractory AML and high-risk MDS. The study will explore escalating doses ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  2. A Safety and Pharmacology Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

    ... hypomethylating agents(s) (HMAs) or have relapsed or are refractory to prior HMA therapy. The primary objectives of this study are ...

    Clinical Trial last updated 04/27/2016 - 9:57am.

  3. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... syndromes (MDS): any of these categories - refractory anemia with transfusion dependence, refractory anemia with ANC< 500/microL, refractory anemia with excess of ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  4. Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

    ... risk myelodysplastic syndrome (MDS) that is relapsed/ refractory to erythropoiesis-stimulating agent (ESA) treatment. ...

    Clinical Trial last updated 04/20/2016 - 3:39pm.

  5. Myelodysplastic Syndromes and autoimmune disorders: Cause or consequence?

    ... neutrophilic dermatosis. Vasculitis is most common in refractory anemia with excess blasts (RAEB) and chronic ...

    Research Review last updated 05/02/2016 - 9:18am.

  6. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... high risk for relapse, or second or third CR, or relapse/ refractory less than or equal to 10% blasts in bone marrow , ... component is in CR. Hodgkin's lymphoma that is primary refractory or relapsed not suitable for other therapy and in PR or CR or small ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  7. Amer Zeidan, M.D.

    ... area is the development of novel therapies for MDS and refractory myeloid malignancies with a focus on immune therapy including ...

    Bio last updated 03/11/2016 - 1:41pm.

  8. Phoenix Ho, MD

    ... (MDS), and childhood leukemia, including relapsed and refractory disease Clinical Interests: Inherited Bone Marrow ...

    Bio last updated 03/11/2016 - 1:41pm.

  9. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... 2nd or greater complete remission, partial remission, or refractory relapse Chronic lymphocytic leukemia (CLL), Rai Stage 2-4, ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  10. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Leukemia (untreated, in remission or with refractory or relapsed disease) Donors will be either human ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.